Global Pet Vaccine Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Pet Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Pet Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Pet Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Vaccine market, reaching US$ million by the year 2028. As for the Europe Pet Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pet Vaccine players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Pet Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Pet Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Pet Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Vaccine market, reaching US$ million by the year 2028. As for the Europe Pet Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pet Vaccine players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Canine
- Avian
- Feline
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer Healthcare
- Vetoquinol S.A
- Boehringer Ingelheim
- Ceva
- Eli Lilly
- Heska Co.
- Merck Animal Health
- Merial (Sanofi)
- Virbac
- Zoetis (Pfizer)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Pet Vaccine Segment by Type
2.2.1 Attenuated Live Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Inactivated Vaccines
2.2.4 Subunit Vaccines
2.2.5 Toxoid Vaccines
2.2.6 DNA Vaccines
2.2.7 Recombinant Vaccines
2.3 Pet Vaccine Sales by Type
2.3.1 Global Pet Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Vaccine Sale Price by Type (2017-2022)
2.4 Pet Vaccine Segment by Application
2.4.1 Canine
2.4.2 Avian
2.4.3 Feline
2.5 Pet Vaccine Sales by Application
2.5.1 Global Pet Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Vaccine Sale Price by Application (2017-2022)
3 GLOBAL PET VACCINE BY COMPANY
3.1 Global Pet Vaccine Breakdown Data by Company
3.1.1 Global Pet Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Pet Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Pet Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Vaccine Revenue by Company (2020-2022)
3.2.2 Global Pet Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Pet Vaccine Sale Price by Company
3.4 Key Manufacturers Pet Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Vaccine Product Location Distribution
3.4.2 Players Pet Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pet Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Vaccine Annual Revenue by Geographic Region
4.2 World Historic Pet Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Vaccine Annual Revenue by Country/Region
4.3 Americas Pet Vaccine Sales Growth
4.4 APAC Pet Vaccine Sales Growth
4.5 Europe Pet Vaccine Sales Growth
4.6 Middle East & Africa Pet Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pet Vaccine Sales by Country
5.1.1 Americas Pet Vaccine Sales by Country (2017-2022)
5.1.2 Americas Pet Vaccine Revenue by Country (2017-2022)
5.2 Americas Pet Vaccine Sales by Type
5.3 Americas Pet Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Vaccine Sales by Region
6.1.1 APAC Pet Vaccine Sales by Region (2017-2022)
6.1.2 APAC Pet Vaccine Revenue by Region (2017-2022)
6.2 APAC Pet Vaccine Sales by Type
6.3 APAC Pet Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Vaccine by Country
7.1.1 Europe Pet Vaccine Sales by Country (2017-2022)
7.1.2 Europe Pet Vaccine Revenue by Country (2017-2022)
7.2 Europe Pet Vaccine Sales by Type
7.3 Europe Pet Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Vaccine by Country
8.1.1 Middle East & Africa Pet Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Vaccine Sales by Type
8.3 Middle East & Africa Pet Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Vaccine
10.3 Manufacturing Process Analysis of Pet Vaccine
10.4 Industry Chain Structure of Pet Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Vaccine Distributors
11.3 Pet Vaccine Customer
12 WORLD FORECAST REVIEW FOR PET VACCINE BY GEOGRAPHIC REGION
12.1 Global Pet Vaccine Market Size Forecast by Region
12.1.1 Global Pet Vaccine Forecast by Region (2023-2028)
12.1.2 Global Pet Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Vaccine Forecast by Type
12.7 Global Pet Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Pet Vaccine Product Offered
13.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Pet Vaccine Product Offered
13.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Pet Vaccine Product Offered
13.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Pet Vaccine Product Offered
13.4.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Pet Vaccine Product Offered
13.5.3 Eli Lilly Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska Co.
13.6.1 Heska Co. Company Information
13.6.2 Heska Co. Pet Vaccine Product Offered
13.6.3 Heska Co. Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Heska Co. Main Business Overview
13.6.5 Heska Co. Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Pet Vaccine Product Offered
13.7.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Pet Vaccine Product Offered
13.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Pet Vaccine Product Offered
13.9.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Zoetis (Pfizer)
13.10.1 Zoetis (Pfizer) Company Information
13.10.2 Zoetis (Pfizer) Pet Vaccine Product Offered
13.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zoetis (Pfizer) Main Business Overview
13.10.5 Zoetis (Pfizer) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Pet Vaccine Segment by Type
2.2.1 Attenuated Live Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Inactivated Vaccines
2.2.4 Subunit Vaccines
2.2.5 Toxoid Vaccines
2.2.6 DNA Vaccines
2.2.7 Recombinant Vaccines
2.3 Pet Vaccine Sales by Type
2.3.1 Global Pet Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Vaccine Sale Price by Type (2017-2022)
2.4 Pet Vaccine Segment by Application
2.4.1 Canine
2.4.2 Avian
2.4.3 Feline
2.5 Pet Vaccine Sales by Application
2.5.1 Global Pet Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Vaccine Sale Price by Application (2017-2022)
3 GLOBAL PET VACCINE BY COMPANY
3.1 Global Pet Vaccine Breakdown Data by Company
3.1.1 Global Pet Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Pet Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Pet Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Vaccine Revenue by Company (2020-2022)
3.2.2 Global Pet Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Pet Vaccine Sale Price by Company
3.4 Key Manufacturers Pet Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Vaccine Product Location Distribution
3.4.2 Players Pet Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pet Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Vaccine Annual Revenue by Geographic Region
4.2 World Historic Pet Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Vaccine Annual Revenue by Country/Region
4.3 Americas Pet Vaccine Sales Growth
4.4 APAC Pet Vaccine Sales Growth
4.5 Europe Pet Vaccine Sales Growth
4.6 Middle East & Africa Pet Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pet Vaccine Sales by Country
5.1.1 Americas Pet Vaccine Sales by Country (2017-2022)
5.1.2 Americas Pet Vaccine Revenue by Country (2017-2022)
5.2 Americas Pet Vaccine Sales by Type
5.3 Americas Pet Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Vaccine Sales by Region
6.1.1 APAC Pet Vaccine Sales by Region (2017-2022)
6.1.2 APAC Pet Vaccine Revenue by Region (2017-2022)
6.2 APAC Pet Vaccine Sales by Type
6.3 APAC Pet Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Vaccine by Country
7.1.1 Europe Pet Vaccine Sales by Country (2017-2022)
7.1.2 Europe Pet Vaccine Revenue by Country (2017-2022)
7.2 Europe Pet Vaccine Sales by Type
7.3 Europe Pet Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Vaccine by Country
8.1.1 Middle East & Africa Pet Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Vaccine Sales by Type
8.3 Middle East & Africa Pet Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Vaccine
10.3 Manufacturing Process Analysis of Pet Vaccine
10.4 Industry Chain Structure of Pet Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Vaccine Distributors
11.3 Pet Vaccine Customer
12 WORLD FORECAST REVIEW FOR PET VACCINE BY GEOGRAPHIC REGION
12.1 Global Pet Vaccine Market Size Forecast by Region
12.1.1 Global Pet Vaccine Forecast by Region (2023-2028)
12.1.2 Global Pet Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Vaccine Forecast by Type
12.7 Global Pet Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Pet Vaccine Product Offered
13.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Pet Vaccine Product Offered
13.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Pet Vaccine Product Offered
13.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Pet Vaccine Product Offered
13.4.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Pet Vaccine Product Offered
13.5.3 Eli Lilly Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska Co.
13.6.1 Heska Co. Company Information
13.6.2 Heska Co. Pet Vaccine Product Offered
13.6.3 Heska Co. Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Heska Co. Main Business Overview
13.6.5 Heska Co. Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Pet Vaccine Product Offered
13.7.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Pet Vaccine Product Offered
13.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Pet Vaccine Product Offered
13.9.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Zoetis (Pfizer)
13.10.1 Zoetis (Pfizer) Company Information
13.10.2 Zoetis (Pfizer) Pet Vaccine Product Offered
13.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zoetis (Pfizer) Main Business Overview
13.10.5 Zoetis (Pfizer) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Attenuated Live Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Inactivated Vaccines
Table 6. Major Players of Subunit Vaccines
Table 7. Major Players of Toxoid Vaccines
Table 8. Major Players of DNA Vaccines
Table 9. Major Players of Recombinant Vaccines
Table 10. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 11. Global Pet Vaccine Sales Market Share by Type (2017-2022)
Table 12. Global Pet Vaccine Revenue by Type (2017-2022) & ($ million)
Table 13. Global Pet Vaccine Revenue Market Share by Type (2017-2022)
Table 14. Global Pet Vaccine Sale Price by Type (2017-2022) & (USD/Dose)
Table 15. Global Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 16. Global Pet Vaccine Sales Market Share by Application (2017-2022)
Table 17. Global Pet Vaccine Revenue by Application (2017-2022)
Table 18. Global Pet Vaccine Revenue Market Share by Application (2017-2022)
Table 19. Global Pet Vaccine Sale Price by Application (2017-2022) & (USD/Dose)
Table 20. Global Pet Vaccine Sales by Company (2020-2022) & (K Doses)
Table 21. Global Pet Vaccine Sales Market Share by Company (2020-2022)
Table 22. Global Pet Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Pet Vaccine Revenue Market Share by Company (2020-2022)
Table 24. Global Pet Vaccine Sale Price by Company (2020-2022) & (USD/Dose)
Table 25. Key Manufacturers Pet Vaccine Producing Area Distribution and Sales Area
Table 26. Players Pet Vaccine Products Offered
Table 27. Pet Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Pet Vaccine Sales by Geographic Region (2017-2022) & (K Doses)
Table 31. Global Pet Vaccine Sales Market Share Geographic Region (2017-2022)
Table 32. Global Pet Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Pet Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Pet Vaccine Sales by Country/Region (2017-2022) & (K Doses)
Table 35. Global Pet Vaccine Sales Market Share by Country/Region (2017-2022)
Table 36. Global Pet Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Pet Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 39. Americas Pet Vaccine Sales Market Share by Country (2017-2022)
Table 40. Americas Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 42. Americas Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 43. Americas Pet Vaccine Sales Market Share by Type (2017-2022)
Table 44. Americas Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 45. Americas Pet Vaccine Sales Market Share by Application (2017-2022)
Table 46. APAC Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 47. APAC Pet Vaccine Sales Market Share by Region (2017-2022)
Table 48. APAC Pet Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Pet Vaccine Revenue Market Share by Region (2017-2022)
Table 50. APAC Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. APAC Pet Vaccine Sales Market Share by Type (2017-2022)
Table 52. APAC Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 53. APAC Pet Vaccine Sales Market Share by Application (2017-2022)
Table 54. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 55. Europe Pet Vaccine Sales Market Share by Country (2017-2022)
Table 56. Europe Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 58. Europe Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Pet Vaccine Sales Market Share by Type (2017-2022)
Table 60. Europe Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 61. Europe Pet Vaccine Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 63. Middle East & Africa Pet Vaccine Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 67. Middle East & Africa Pet Vaccine Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 69. Middle East & Africa Pet Vaccine Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Pet Vaccine
Table 71. Key Market Challenges & Risks of Pet Vaccine
Table 72. Key Industry Trends of Pet Vaccine
Table 73. Pet Vaccine Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Pet Vaccine Distributors List
Table 76. Pet Vaccine Customer List
Table 77. Global Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 78. Global Pet Vaccine Sales Market Forecast by Region
Table 79. Global Pet Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Pet Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 82. Americas Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 84. APAC Pet Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 86. Europe Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 88. Middle East & Africa Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Pet Vaccine Sales Forecast by Type (2023-2028) & (K Doses)
Table 90. Global Pet Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Pet Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Pet Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Pet Vaccine Sales Forecast by Application (2023-2028) & (K Doses)
Table 94. Global Pet Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Pet Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Pet Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 97. Bayer Healthcare Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Healthcare Pet Vaccine Product Offered
Table 99. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Bayer Healthcare Main Business
Table 101. Bayer Healthcare Latest Developments
Table 102. Vetoquinol S.A Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Vetoquinol S.A Pet Vaccine Product Offered
Table 104. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Vetoquinol S.A Main Business
Table 106. Vetoquinol S.A Latest Developments
Table 107. Boehringer Ingelheim Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim Pet Vaccine Product Offered
Table 109. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. Ceva Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Ceva Pet Vaccine Product Offered
Table 114. Ceva Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 115. Ceva Main Business
Table 116. Ceva Latest Developments
Table 117. Eli Lilly Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Pet Vaccine Product Offered
Table 119. Eli Lilly Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. Heska Co. Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Heska Co. Pet Vaccine Product Offered
Table 124. Heska Co. Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 125. Heska Co. Main Business
Table 126. Heska Co. Latest Developments
Table 127. Merck Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Merck Animal Health Pet Vaccine Product Offered
Table 129. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 130. Merck Animal Health Main Business
Table 131. Merck Animal Health Latest Developments
Table 132. Merial (Sanofi) Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Merial (Sanofi) Pet Vaccine Product Offered
Table 134. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 135. Merial (Sanofi) Main Business
Table 136. Merial (Sanofi) Latest Developments
Table 137. Virbac Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Virbac Pet Vaccine Product Offered
Table 139. Virbac Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 140. Virbac Main Business
Table 141. Virbac Latest Developments
Table 142. Zoetis (Pfizer) Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Zoetis (Pfizer) Pet Vaccine Product Offered
Table 144. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 145. Zoetis (Pfizer) Main Business
Table 146. Zoetis (Pfizer) Latest Developments
Table 1. Pet Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Attenuated Live Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Inactivated Vaccines
Table 6. Major Players of Subunit Vaccines
Table 7. Major Players of Toxoid Vaccines
Table 8. Major Players of DNA Vaccines
Table 9. Major Players of Recombinant Vaccines
Table 10. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 11. Global Pet Vaccine Sales Market Share by Type (2017-2022)
Table 12. Global Pet Vaccine Revenue by Type (2017-2022) & ($ million)
Table 13. Global Pet Vaccine Revenue Market Share by Type (2017-2022)
Table 14. Global Pet Vaccine Sale Price by Type (2017-2022) & (USD/Dose)
Table 15. Global Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 16. Global Pet Vaccine Sales Market Share by Application (2017-2022)
Table 17. Global Pet Vaccine Revenue by Application (2017-2022)
Table 18. Global Pet Vaccine Revenue Market Share by Application (2017-2022)
Table 19. Global Pet Vaccine Sale Price by Application (2017-2022) & (USD/Dose)
Table 20. Global Pet Vaccine Sales by Company (2020-2022) & (K Doses)
Table 21. Global Pet Vaccine Sales Market Share by Company (2020-2022)
Table 22. Global Pet Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Pet Vaccine Revenue Market Share by Company (2020-2022)
Table 24. Global Pet Vaccine Sale Price by Company (2020-2022) & (USD/Dose)
Table 25. Key Manufacturers Pet Vaccine Producing Area Distribution and Sales Area
Table 26. Players Pet Vaccine Products Offered
Table 27. Pet Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Pet Vaccine Sales by Geographic Region (2017-2022) & (K Doses)
Table 31. Global Pet Vaccine Sales Market Share Geographic Region (2017-2022)
Table 32. Global Pet Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Pet Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Pet Vaccine Sales by Country/Region (2017-2022) & (K Doses)
Table 35. Global Pet Vaccine Sales Market Share by Country/Region (2017-2022)
Table 36. Global Pet Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Pet Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 39. Americas Pet Vaccine Sales Market Share by Country (2017-2022)
Table 40. Americas Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 42. Americas Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 43. Americas Pet Vaccine Sales Market Share by Type (2017-2022)
Table 44. Americas Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 45. Americas Pet Vaccine Sales Market Share by Application (2017-2022)
Table 46. APAC Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 47. APAC Pet Vaccine Sales Market Share by Region (2017-2022)
Table 48. APAC Pet Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Pet Vaccine Revenue Market Share by Region (2017-2022)
Table 50. APAC Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. APAC Pet Vaccine Sales Market Share by Type (2017-2022)
Table 52. APAC Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 53. APAC Pet Vaccine Sales Market Share by Application (2017-2022)
Table 54. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 55. Europe Pet Vaccine Sales Market Share by Country (2017-2022)
Table 56. Europe Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 58. Europe Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Pet Vaccine Sales Market Share by Type (2017-2022)
Table 60. Europe Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 61. Europe Pet Vaccine Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 63. Middle East & Africa Pet Vaccine Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Pet Vaccine Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 67. Middle East & Africa Pet Vaccine Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 69. Middle East & Africa Pet Vaccine Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Pet Vaccine
Table 71. Key Market Challenges & Risks of Pet Vaccine
Table 72. Key Industry Trends of Pet Vaccine
Table 73. Pet Vaccine Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Pet Vaccine Distributors List
Table 76. Pet Vaccine Customer List
Table 77. Global Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 78. Global Pet Vaccine Sales Market Forecast by Region
Table 79. Global Pet Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Pet Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 82. Americas Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 84. APAC Pet Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 86. Europe Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 88. Middle East & Africa Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Pet Vaccine Sales Forecast by Type (2023-2028) & (K Doses)
Table 90. Global Pet Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Pet Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Pet Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Pet Vaccine Sales Forecast by Application (2023-2028) & (K Doses)
Table 94. Global Pet Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Pet Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Pet Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 97. Bayer Healthcare Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Healthcare Pet Vaccine Product Offered
Table 99. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Bayer Healthcare Main Business
Table 101. Bayer Healthcare Latest Developments
Table 102. Vetoquinol S.A Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Vetoquinol S.A Pet Vaccine Product Offered
Table 104. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Vetoquinol S.A Main Business
Table 106. Vetoquinol S.A Latest Developments
Table 107. Boehringer Ingelheim Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim Pet Vaccine Product Offered
Table 109. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. Ceva Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Ceva Pet Vaccine Product Offered
Table 114. Ceva Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 115. Ceva Main Business
Table 116. Ceva Latest Developments
Table 117. Eli Lilly Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Pet Vaccine Product Offered
Table 119. Eli Lilly Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. Heska Co. Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Heska Co. Pet Vaccine Product Offered
Table 124. Heska Co. Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 125. Heska Co. Main Business
Table 126. Heska Co. Latest Developments
Table 127. Merck Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Merck Animal Health Pet Vaccine Product Offered
Table 129. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 130. Merck Animal Health Main Business
Table 131. Merck Animal Health Latest Developments
Table 132. Merial (Sanofi) Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Merial (Sanofi) Pet Vaccine Product Offered
Table 134. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 135. Merial (Sanofi) Main Business
Table 136. Merial (Sanofi) Latest Developments
Table 137. Virbac Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Virbac Pet Vaccine Product Offered
Table 139. Virbac Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 140. Virbac Main Business
Table 141. Virbac Latest Developments
Table 142. Zoetis (Pfizer) Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Zoetis (Pfizer) Pet Vaccine Product Offered
Table 144. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 145. Zoetis (Pfizer) Main Business
Table 146. Zoetis (Pfizer) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet Vaccine
Figure 2. Pet Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Vaccine Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Pet Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Attenuated Live Vaccines
Figure 10. Product Picture of Conjugate Vaccines
Figure 11. Product Picture of Inactivated Vaccines
Figure 12. Product Picture of Subunit Vaccines
Figure 13. Product Picture of Toxoid Vaccines
Figure 14. Product Picture of DNA Vaccines
Figure 15. Product Picture of Recombinant Vaccines
Figure 16. Global Pet Vaccine Sales Market Share by Type in 2021
Figure 17. Global Pet Vaccine Revenue Market Share by Type (2017-2022)
Figure 18. Pet Vaccine Consumed in Canine
Figure 19. Global Pet Vaccine Market: Canine (2017-2022) & (K Doses)
Figure 20. Pet Vaccine Consumed in Avian
Figure 21. Global Pet Vaccine Market: Avian (2017-2022) & (K Doses)
Figure 22. Pet Vaccine Consumed in Feline
Figure 23. Global Pet Vaccine Market: Feline (2017-2022) & (K Doses)
Figure 24. Global Pet Vaccine Sales Market Share by Application (2017-2022)
Figure 25. Global Pet Vaccine Revenue Market Share by Application in 2021
Figure 26. Pet Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Pet Vaccine Revenue Market Share by Company in 2021
Figure 28. Global Pet Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Pet Vaccine Revenue Market Share by Geographic Region in 2021
Figure 30. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Figure 31. Global Pet Vaccine Revenue Market Share by Country/Region in 2021
Figure 32. Americas Pet Vaccine Sales 2017-2022 (K Doses)
Figure 33. Americas Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. APAC Pet Vaccine Sales 2017-2022 (K Doses)
Figure 35. APAC Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 36. Europe Pet Vaccine Sales 2017-2022 (K Doses)
Figure 37. Europe Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Pet Vaccine Sales 2017-2022 (K Doses)
Figure 39. Middle East & Africa Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 40. Americas Pet Vaccine Sales Market Share by Country in 2021
Figure 41. Americas Pet Vaccine Revenue Market Share by Country in 2021
Figure 42. United States Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Pet Vaccine Sales Market Share by Region in 2021
Figure 47. APAC Pet Vaccine Revenue Market Share by Regions in 2021
Figure 48. China Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Pet Vaccine Sales Market Share by Country in 2021
Figure 55. Europe Pet Vaccine Revenue Market Share by Country in 2021
Figure 56. Germany Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Pet Vaccine Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Pet Vaccine Revenue Market Share by Country in 2021
Figure 63. Egypt Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Pet Vaccine in 2021
Figure 69. Manufacturing Process Analysis of Pet Vaccine
Figure 70. Industry Chain Structure of Pet Vaccine
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Pet Vaccine
Figure 2. Pet Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Vaccine Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Pet Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Attenuated Live Vaccines
Figure 10. Product Picture of Conjugate Vaccines
Figure 11. Product Picture of Inactivated Vaccines
Figure 12. Product Picture of Subunit Vaccines
Figure 13. Product Picture of Toxoid Vaccines
Figure 14. Product Picture of DNA Vaccines
Figure 15. Product Picture of Recombinant Vaccines
Figure 16. Global Pet Vaccine Sales Market Share by Type in 2021
Figure 17. Global Pet Vaccine Revenue Market Share by Type (2017-2022)
Figure 18. Pet Vaccine Consumed in Canine
Figure 19. Global Pet Vaccine Market: Canine (2017-2022) & (K Doses)
Figure 20. Pet Vaccine Consumed in Avian
Figure 21. Global Pet Vaccine Market: Avian (2017-2022) & (K Doses)
Figure 22. Pet Vaccine Consumed in Feline
Figure 23. Global Pet Vaccine Market: Feline (2017-2022) & (K Doses)
Figure 24. Global Pet Vaccine Sales Market Share by Application (2017-2022)
Figure 25. Global Pet Vaccine Revenue Market Share by Application in 2021
Figure 26. Pet Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Pet Vaccine Revenue Market Share by Company in 2021
Figure 28. Global Pet Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Pet Vaccine Revenue Market Share by Geographic Region in 2021
Figure 30. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Figure 31. Global Pet Vaccine Revenue Market Share by Country/Region in 2021
Figure 32. Americas Pet Vaccine Sales 2017-2022 (K Doses)
Figure 33. Americas Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. APAC Pet Vaccine Sales 2017-2022 (K Doses)
Figure 35. APAC Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 36. Europe Pet Vaccine Sales 2017-2022 (K Doses)
Figure 37. Europe Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Pet Vaccine Sales 2017-2022 (K Doses)
Figure 39. Middle East & Africa Pet Vaccine Revenue 2017-2022 ($ Millions)
Figure 40. Americas Pet Vaccine Sales Market Share by Country in 2021
Figure 41. Americas Pet Vaccine Revenue Market Share by Country in 2021
Figure 42. United States Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Pet Vaccine Sales Market Share by Region in 2021
Figure 47. APAC Pet Vaccine Revenue Market Share by Regions in 2021
Figure 48. China Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Pet Vaccine Sales Market Share by Country in 2021
Figure 55. Europe Pet Vaccine Revenue Market Share by Country in 2021
Figure 56. Germany Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Pet Vaccine Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Pet Vaccine Revenue Market Share by Country in 2021
Figure 63. Egypt Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Pet Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Pet Vaccine in 2021
Figure 69. Manufacturing Process Analysis of Pet Vaccine
Figure 70. Industry Chain Structure of Pet Vaccine
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
